Martin Jefson is the founder of Pinteon Therapeutics. Pinteon Therapeutics has raised $21M in total funding. Latest round: Series A.
Martin Jefson, Ph.D. was the CEO of Pinteon Therapeutics, a clinical-stage CNS company focused on tauopathies. Before joining Pinteon, he worked as a pharmaceutical research consultant and was the founding Chief Scientific Officer of Rodin Therapeutics and Ataxion. He started his career at Pfizer Central Research in 1982, ultimately becoming head of CNS research.
Full founder directory · Investor directory · Company funding database · Fundraising library